These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2319260)

  • 1. Therapeutic efficacy of recombinant tumor necrosis factor alpha in an experimental model of human prostatic carcinoma.
    Sherwood ER; Pitt Ford TR; Lee C; Kozlowski JM
    J Biol Response Mod; 1990 Feb; 9(1):44-52. PubMed ID: 2319260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
    Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-arterial administration of TNF-alpha followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma.
    Badgwell BD; Valentino DJ; Jeffes EB; Dieffenbach K; Dulkanchainun SB; Yamamoto RS; Granger GA; Jakowatz JG; Carson WE
    Cancer Immunol Immunother; 2003 Jan; 52(1):10-6. PubMed ID: 12536235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro.
    Okamoto M; Lee C; Oyasu R
    Cancer Res; 1997 Jan; 57(1):141-6. PubMed ID: 8988055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
    Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR
    Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor synergism between recombinant human tumor necrosis factor and recombinant human interferon-r.
    Watanabe N; Niitsu Y; Yamauchi N; Umeno H; Sone H; Neda H; Urushizaki I
    J Biol Response Mod; 1988 Feb; 7(1):24-31. PubMed ID: 2453618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia against heterotransplanted human prostatic carcinoma and its lymph node metastasis in nude mice.
    Hachiya T; Okada K; Sakurai A; Satomi N; Haranaka K
    Mol Biother; 1992 Mar; 4(1):34-9. PubMed ID: 1627271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
    Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines.
    Borsellino N; Belldegrun A; Bonavida B
    Cancer Res; 1995 Oct; 55(20):4633-9. PubMed ID: 7553641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor.
    Creasey AA; Reynolds MT; Laird W
    Cancer Res; 1986 Nov; 46(11):5687-90. PubMed ID: 3756916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of tumor necrosis factor-alpha with sulindac augments its apoptotic potential and suppresses tumor growth of human carcinoma cells in nude mice.
    Yasui H; Adachi M; Imai K
    Cancer; 2003 Mar; 97(6):1412-20. PubMed ID: 12627504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
    Liu Y; Saxena A; Zheng C; Carlsen S; Xiang J
    J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
    Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
    Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
    Gnant MF; Berger AC; Huang J; Puhlmann M; Wu PC; Merino MJ; Bartlett DL; Alexander HR; Libutti SK
    Cancer Res; 1999 Sep; 59(18):4668-74. PubMed ID: 10493523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic interleukin 2 therapy for human prostate tumors in a nude mouse model.
    Triest JA; Grignon DJ; Cher ML; Kocheril SV; Montecillo EJ; Talati B; Tekyi-Mensah S; Pontes JE; Hillman GG
    Clin Cancer Res; 1998 Aug; 4(8):2009-14. PubMed ID: 9717832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
    Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
    Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.
    Xu X; Kreye E; Kuo CB; Walker AM
    Cancer Res; 2001 Aug; 61(16):6098-104. PubMed ID: 11507059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative and cytotoxic effects of single and combined treatment with tumor necrosis factor alpha and/or alpha interferon on a human renal cell carcinoma xenotransplanted into nu/nu mice: cell kinetic studies.
    Baisch H; Otto U; Klöppel G
    Cancer Res; 1990 Oct; 50(19):6389-95. PubMed ID: 2400997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF) alpha, and TNF-related apoptosis-inducing ligand in prostate cancer.
    An J; Sun YP; Adams J; Fisher M; Belldegrun A; Rettig MB
    Clin Cancer Res; 2003 Oct; 9(12):4537-45. PubMed ID: 14555528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.